{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:39:01Z","timestamp":1775767141295,"version":"3.50.1"},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,20]]},"DOI":"10.18632\/oncotarget.13454","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T03:21:50Z","timestamp":1479525710000},"page":"85515-85528","source":"Crossref","is-referenced-by-count":19,"title":["Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption"],"prefix":"10.18632","volume":"7","author":[{"given":"Haijun","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China"},{"name":"Department of Hematology, Anqing Municipal Hospital of Anhui Medical University, Anqing, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manman","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinodh","family":"Kannappan","sequence":"additional","affiliation":[{"name":"Research Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Research Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China"},{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V99.3.863","article-title":"Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study","volume":"99","author":"Di Raimondo","year":"2002","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Hoelzer","year":"2011","journal-title":"Journal of clinical oncology"},{"key":"3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Goldstone","year":"2007","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2011-12-399287","article-title":"Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation","volume":"120","author":"Serve","year":"2012","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1021\/ja00775a078","article-title":"Triptolide and tripdiolide, novel antileukemicditerpenoi-dtriepoxides from Tripterygium wilfordii","volume":"94","author":"Bryan","year":"1972","journal-title":"J Am Chem Soc"},{"key":"6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1080\/14786419.2010.541395","article-title":"Reversal effects of traditional Chinese herbs on multidrug resistance in cancer cells","volume":"25","author":"Kong","year":"2011","journal-title":"Nat Prod Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2217\/pgs.13.122","article-title":"Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1alpha and Nrf2","volume":"14","author":"Xu","year":"2013","journal-title":"Pharmacogenomics"},{"key":"8","doi-asserted-by":"publisher","first-page":"8360","DOI":"10.18632\/oncotarget.7073","article-title":"Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3892\/ol.2013.1524","article-title":"Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species\/nuclear factor-kappaB pathway in SKOV3 platinum-resistant human ovarian cancer cells","volume":"6","author":"Huang","year":"2013","journal-title":"Oncol Lett"},{"key":"10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1022945107762","article-title":"The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update","volume":"8","author":"Lawen","year":"2003","journal-title":"Apoptosis"},{"key":"11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mrfmmm.2015.01.007","article-title":"Anthracyclines induce double-strand DNA breaks at active gene promoters","volume":"773","author":"Henikoffa","year":"2015","journal-title":"Mutat Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1016\/S0021-9258(19)70512-2","article-title":"Correlation of cytotoxicity with incorporation of ara-C into DNA","volume":"255","author":"Beardsley","year":"1980","journal-title":"The Journal of biological chemistry"},{"key":"13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"gammaH2AX: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"Karagiannis","year":"2010","journal-title":"Leukemia"},{"key":"14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.dnarep.2004.03.024","article-title":"H2AX: the histone guardian of the genome","volume":"3","author":"Nussenzweig","year":"2004","journal-title":"DNA repair"},{"key":"15","first-page":"144","article-title":"[Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii]","volume":"10","author":"Li","year":"1990","journal-title":"Zhong Xi Yi Jie He ZaZhi"},{"key":"16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2141.2002.03706.x","article-title":"A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group","volume":"118","author":"Barisone","year":"2002","journal-title":"British journal of haematology"},{"key":"17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00280-006-0332-4","article-title":"High-dose idarubicinin combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study","volume":"59","author":"Morra","year":"2007","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.leukres.2008.06.028","article-title":"In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy","volume":"33","author":"Mayer","year":"2009","journal-title":"Leukemia research"},{"key":"19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3109\/10428194.2013.856428","article-title":"Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia","volume":"55","author":"Liedtke","year":"2014","journal-title":"Leukemia & lymphoma"},{"key":"20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.freeradbiomed.2008.07.018","article-title":"DNA damage-induced reactive oxygen species (ROS) stress response in Saccharomyces cerevisiae","volume":"45","author":"Doetsch","year":"2008","journal-title":"Free RadicBiol Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tibs.2010.04.002","article-title":"Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes","volume":"35","author":"Chandel","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1158\/1078-0432.CCR-06-2082","article-title":"Reactive oxygen species: a breath of life or death?","volume":"13","author":"Meyskens","year":"2007","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14712\/fb2015061050195","article-title":"Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1\/DDP Nasopharyngeal Cancer Cells","volume":"61","author":"Liu","year":"2015","journal-title":"Folia biologica"},{"key":"24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2005-09-3898","article-title":"Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells","volume":"108","author":"Andreeff","year":"2006","journal-title":"Blood"},{"key":"25","first-page":"756","article-title":"Abrogation of Chk1-mediated S\/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells","volume":"25","author":"Pommier","year":"2004","journal-title":"ActaPharmacol Sin"},{"key":"26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40364-015-0043-2","article-title":"Triptolide potentiates lung cancer cells to cisplatin-induced apoptosis by selectively inhibiting the NER activity","volume":"3","author":"Xu","year":"2015","journal-title":"Biomarker research"},{"key":"27","first-page":"337","article-title":"[Establishment of an imatinibresistant cell line K562\/G01 and its characterization]","volume":"25","author":"Yang","year":"2004","journal-title":"ZhonghuaXue Ye XueZaZhi"},{"key":"28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.leu.2401814","article-title":"Kinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia","volume":"14","author":"Scheuermann","year":"2000","journal-title":"Leukemia"},{"key":"29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fct.2013.03.044","article-title":"Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodents","volume":"57","author":"Yang","year":"2013","journal-title":"Food Chem Toxicol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T18:07:49Z","timestamp":1718906869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,19]]},"references-count":29,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12,20]]}},"alternative-id":["13454","27888802"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13454","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,19]]}}}